Abdel Omri obtained his PhD from the Université de Montréal in 1996. After completing postdoctoral fellowships at McGill University and the University of Toronto (1996-1998), he spent more than 2 years as a Research associate at NRC, Institute of Biological Sciences in Ottawa (1998 to 2000). Dr. Omri is currently a full Professor in the Department of Chemistry and Biochemistry with a cross appointment in the Department of Biology, the Biomolecular Sciences PhD Programme, and the School of Rural and Northern Health PhD Programme.

Dr. Omri’s research interests are focused on lipid-based drug and vaccine delivery systems. His laboratory employs a multi-disciplinary approach in addressing the antimicrobial resistance of Gram negative bacteria in cystic fibrosis patients and in medical devices implants. Dr. Omri is also involved in the education of undergraduate and graduate students through the coordination of several calendar courses in biochemistry, pharmacology and toxicology and pharmaceutical technology. In addition to his research, Dr. Omri is actively involved in the research training of both undergraduate and graduate students. Currently, in his lab there are 4 undergraduate, 2 Masters and 4 PhD students, all examining the role of liposomes as a delivery system in potentiating the antimicrobial activity of several antibiotics.

Dr. Omri has been a member of several committees at Laurentian University for several years (2000-present). He has most recently served as a member of the committee for evaluation of the renewal for the vice-president (Francophone Affairs, LU). Dr. Omri has also served in administrative capacities in several international scientific societies. He has published over 30 peer-reviewed research articles on various aspects of drug delivery and targeting as well as several book chapters and books (2). He has served on a number of Editorial Boards and Granting Agencies in Canada and abroad. In addition, Dr. Omri has 2 patents in relation to vaccine delivery systems.